Merck Tbk. vs Surya Biru Murni Acetylene Tbk. — how do they compare? Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume), while Surya Biru Murni Acetylene Tbk. trades at Rp108 (market cap 98.57B, 330.2K 24h volume). The key difference: Merck Tbk. is far larger — about 17.2× Surya Biru Murni Acetylene Tbk.'s market cap, and Surya Biru Murni Acetylene Tbk. is more actively traded (330.2K versus 37.6K). Which is the better fit depends on your goals.
| MERK | SBMA | |
|---|---|---|
Market Cap | 1.7T | 98.57B |
Volume | 37.6K | 330.2K |
Lot | 376 | 3.3K |
Turnover | 144.47M | 35.06M |
Average Price | 3,842.23 | 106.16 |
Value | 144.47M | 35.06M |
Indicative Equilibrium Price | 3,840 | — |
Indicative Equilibrium Volume | 7 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →PT Surya Biru Murni Acetylene Tbk (the Company) was established in Balikpapan based on Notarial Deed No. 57 of Mohamad Rasjid Umar, S.H., dated October 25, 1980. The Company started its commercial operations in 1982.
Read more on SBMA →